332 related articles for article (PubMed ID: 26846711)
21. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
22. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
23. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma.
Li H; Liu XW; Geng ZJ; Wang DL; Xie CM
Dentomaxillofac Radiol; 2015; 44(3):20140126. PubMed ID: 25430557
[TBL] [Abstract][Full Text] [Related]
25. Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.
Yi Z; Xie M; Shi G; Cheng Z; Zeng H; Jiang N; Wu Z
Eur Radiol; 2022 Mar; 32(3):1601-1610. PubMed ID: 34491383
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
Sun D; Wu X; Wang L; Li G; Huang J; Li Y
Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
[TBL] [Abstract][Full Text] [Related]
27. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
Liu K; Xie P; Peng W; Zhou Z
J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
29. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
[TBL] [Abstract][Full Text] [Related]
32. Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer.
Lee HS; Kim SH; Kang BJ; Baek JE; Song BJ
Acad Radiol; 2016 Apr; 23(4):446-56. PubMed ID: 26852247
[TBL] [Abstract][Full Text] [Related]
33. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
[TBL] [Abstract][Full Text] [Related]
35. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
[TBL] [Abstract][Full Text] [Related]
37. Value of Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Treatment Outcomes in Nasopharyngeal Carcinoma.
Paprad T; Lertbutsayanukul C; Jittapiromsak N
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):664-672. PubMed ID: 35483078
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of using dynamic contrast-enhanced MRI for differentiating thymic carcinoma from thymic lymphoma based on semi-quantitative and quantitative models.
Shen J; Xue L; Zhong Y; Wu YL; Zhang W; Yu TF
Clin Radiol; 2020 Jul; 75(7):560.e19-560.e25. PubMed ID: 32197918
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
